1211581-47-3 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 2-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate is used as a building block for the synthesis of other compounds with similar structural features, which may have biological activity of interest for drug development.
Used in Materials Science:
Tert-butyl 2-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate is used as a component in the development of new materials, potentially due to its unique structural properties and the possibility of creating novel compounds with desired characteristics.
Used in Scientific Research:
Tert-butyl 2-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate is used as a subject of study in various research fields, including chemistry and biology, to explore its properties, reactivity, and potential applications in creating new compounds or understanding its biological effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1211581-47-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,1,5,8 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1211581-47:
(9*1)+(8*2)+(7*1)+(6*1)+(5*5)+(4*8)+(3*1)+(2*4)+(1*7)=113
113 % 10 = 3
So 1211581-47-3 is a valid CAS Registry Number.
1211581-47-3Relevant academic research and scientific papers
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X
-
Paragraph 0073-0074; 0146; 0187, (2020/07/15)
The disclosure provides novel chemical compounds useful as inhibitors of ubiquitin specific peptidase 9X (USP9X). USP9X inhibiting compounds are useful in the treatment of disease and disorders associated with modulation of USP9X, such as cancer.
NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
-
Page/Page column 66, (2020/01/08)
The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Method for selective dehalogenation in pyrimidine fused ring
-
Paragraph 0060; 0061; 0062, (2016/10/10)
The invention discloses a method for selective dehalogenation in pyrimidine fused ring. Through heating reaction between zinc powder and acetic acid solution, selective dehalogenation is conducted on pyrimidine ring to maintain original substituents on pyrimidine ring and fused ring. The method comprises few operation steps with high yield, and is applicable to mass production.
